A few weeks ago, I attended the Proteomic Forum in Berlin, which was held in The Technical University, from 22nd to 25th March. It was my first time in Berlin, a cosmopolitan city with a fascinating mix of people where, just as in London, anything can happen. Since it was my first visit to Berlin, it was also the first time I attended this event, and a great opportunity for me to meet with German scientists and my Waters colleagues based in Germany.
As usual, the interesting content of the program kept me busy all day long, but I had the opportunity to do some sightseeing during the evenings: from the Brandenburg Gate to Potsdamer Platz, an entire quarter built from scratch since 1995, after the Wall came down.
The program was rich and diverse, with discussions on a range of approaches from top-down proteomics to imaging techniques, but common themes across the varying approaches were the importance of PTMs and pathway analysis. Pathway analysis is actually one of the areas we focused on with the release of the latest version of Progenesis QI for Proteomics, helping scientists to understand the biological context of their results. For instance, with the pathway tool IMPaLA, which is directly supported by Progenesis, you can go further and get a biological interpretation of your quantitative results.
IMPaLA can also easily merge results from a proteomics experiment and a metabolomics experiment, so this functionality is also available in our software for small molecules, Progenesis QI. I had the opportunity to demonstrate this at the Gen2Bio conference, a regional metabolomics meeting held in La Baule, Western France, just after the proteomic forum.
If you want to know more about the latest releases of Progenesis QI or Progenesis QI for proteomics, or want to try it with your own data, please get in touch. If you’d like the opportunity to catch up with us in person at a future event, keep an eye on our events page to see where we’re headed over the next few months.